Turning foes to friends: targeting cancer-associated fibroblasts

By Xueman Chen, E. Song. Nature reviews. Drug discovery, 2018

1,570 citations recorded by the source corpus.

Subfields: Cell Biology, Molecular Biology, Oncology

View Paper: https://www.semanticscholar.org/paper/63b773da7456d2814d5e65912ad690d7799f1a6b

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cell Biology

1. Walter Kolch

In Molecular Biology

1. Qingxiang Zeng
2. Walter Kolch
3. Junjiang Liu
4. Jin Yang
5. J. Mu
6. Shuzhi Deng
7. Fanglong Wu
8. Ye Wang

In Oncology

1. Walter Kolch

Citations in the corpus

• Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives (2021, background): “CAFs are composed of not only heterogeneous subsets with distinct phenotypes but also heterogeneous subpopulations with diverse functions [9, 30].”
• Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer (2021, background): “The heterogeneity of CAFs in the same organ or tissue is likely held to depend on their precursor fibroblasts.(53) Generally, CAFs are derived from the activated local tissueresident fibroblasts, fibrocytes recruited from bone marrow, mesenchymal stem cells (MSCs) and stellate cells, or are the prod”
• Targeting MAPK Signaling in Cancer: Mechanisms of Drug Resistance and Sensitivity (2020, background): “Cancer associated fibroblasts (CAF) play an important part in sustaining and protecting tumor cells and may lend themselves to new unconventional approaches to cancer therapy [123].”